+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Renal Biomarkers Market - Global Forecast 2026-2032- Product Image
Renal Biomarkers Market - Global Forecast 2026-2032- Product Image
New

Renal Biomarkers Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 191 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012348
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The renal biomarkers market is transforming diagnostics and disease management across healthcare, driven by clinical need for earlier detection and operational efficiency. This report delivers actionable insights for senior executives seeking to navigate this rapid evolution and optimize their organizations’ strategies in a dynamic sector.

Market Snapshot: Renal Biomarkers Market Overview

The renal biomarkers market is expanding, having increased from USD 1.54 billion in 2025 to USD 1.68 billion in 2026, and anticipated to reach USD 2.74 billion by 2032 with a CAGR of 8.53%. This growth reflects higher demand for early identification, improved risk assessment, and better monitoring solutions. Market participants are innovating in assay development, incorporating digital data, and responding to shifting regulatory expectations as the landscape quickly advances.

Scope & Segmentation

This report offers an in-depth analysis of the renal biomarker industry by examining the following key segments and factors influencing market trends:

  • Product Types: Covers advanced instruments including immunoassay analyzers, mass spectrometers, spectrophotometers; reagent options such as colorimetric kits, immunoassay kits, mass spectrometry reagents; a range of service offerings including consulting, maintenance, training; and software solutions for laboratory data management and analytics.
  • Biomarker Choices: Encompasses established analytes like creatinine and albumin, as well as innovative markers such as Cystatin C and NGAL, which are supporting more sensitive, earlier intervention in diagnostic workflows.
  • End-User Needs: Addresses the tailored requirements of academic institutions, contract research organizations, hospitals, diagnostic laboratories, and pharmaceutical companies, each aiming for improvement in scalability and adaptability in renal diagnostics.
  • Technologies: Assesses adoption of biosensors, colorimetric assays, immunoassays, and LC-MS technology, each balancing speed, sensitivity, and cost-efficiency considerations to respond to diverse laboratory and clinical priorities.
  • Applications: Supports a variety of use cases including academic research, clinical diagnostics, disease monitoring, and drug development support, emphasizing the interdisciplinary and multi-sectoral scope of renal biomarkers.
  • Sample Modalities: Evaluates the use of serum, plasma, and urine in assay procedures, with attention to calibration, pre-analytical processing, and the implications for analytical accuracy and clinical interpretation.
  • Regions: Covers market progression in the Americas, Europe, Middle East & Africa, and Asia-Pacific, with analysis of infrastructure, manufacturing hubs, and differences in regulatory alignment driving adoption and innovation patterns.

Key Takeaways: Strategic Insights for Decision-Makers

  • Diagnostic platforms are advancing from single-marker use to multi-panel analyte solutions, offering higher analytical accuracy and expedited results for both providers and patients.
  • Vendors increasingly provide bundled offerings, integrating maintenance, training, and analytics to lower barriers for laboratories and drive operational performance.
  • Clinical acceptance now depends on evidence-based validation and enhanced software interoperability, ensuring smooth integration into both clinical and research environments.
  • Cross-industry collaborations among assay developers, equipment manufacturers, and clinical labs are driving robust data integration and supporting improved scalability and traceability.
  • New user priorities emphasize earlier detection, reliable disease monitoring, and data-driven stratification, aligning with trends in personalized healthcare and pharmaceutical development.
  • Regional factors such as standardizing workflows and optimizing supply chains are critical in determining the pace and success of technology adoption and partnership frameworks.

Tariff Impact on Supply and Partnerships

Recent tariff changes in the U.S. have complicated global supply chains for renal diagnostics, leading to adjustments in procurement methods and reagent sourcing strategies. Suppliers are experiencing longer lead times and higher expenses, prompting a shift toward diversifying suppliers and evaluating nearshoring opportunities to bolster supply assurance. Laboratories are tightening reagent inventories and exploring alternative assay options to control costs, while manufacturers are updating pricing structures and service options for increased flexibility. Regulatory requirements and international partnerships now require enhanced documentation and strengthened contract terms to maintain continuous diagnostic and research output.

Methodology & Data Sources

This report builds on primary interviews with laboratory directors, clinical researchers, procurement professionals, and technology leaders across the renal diagnostics sector. Findings are corroborated with secondary sources such as academic literature, regulatory reports, conference materials, and technical datasets, using triangulation and quality assurance to ensure reliability and consistency.

Why This Report Matters

  • Helps industry leaders evaluate and adjust their renal biomarker product portfolios, operational processes, and investment approaches within a changing marketplace.
  • Provides clear guidance for addressing regulatory, supply chain, technology, and validation challenges, supporting both resilience and informed growth.
  • Enables executives to align organizational resources and capabilities with rising clinical, operational, and partnership demands in renal healthcare.

Conclusion

Renal biomarkers are becoming integral to precision diagnostics worldwide. Adapting organizational strategies to changing clinical needs, emerging technologies, and evolving partnerships will be vital for maintaining competitive advantage and supporting sustained clinical integration.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Renal Biomarkers Market, by Product Type
8.1. Instruments
8.1.1. Immunoassay Analyzers
8.1.2. Mass Spectrometers
8.1.3. Spectrophotometers
8.2. Reagents
8.2.1. Colorimetric Kits
8.2.2. Immunoassay Kits
8.2.3. Mass Spectrometry Reagents
8.3. Services
8.3.1. Consulting Services
8.3.2. Maintenance Services
8.3.3. Training Services
8.4. Software
8.4.1. Data Analysis Software
8.4.2. Laboratory Informatics
9. Renal Biomarkers Market, by Biomarker Type
9.1. Albumin
9.2. Creatinine
9.3. Cystatin C
9.4. NGAL
10. Renal Biomarkers Market, by Technology
10.1. Biosensors
10.2. Colorimetric Assay
10.3. Immunoassay
10.4. LC-MS
11. Renal Biomarkers Market, by Sample Type
11.1. Serum Plasma
11.2. Urine
12. Renal Biomarkers Market, by Application
12.1. Academic Research
12.2. Clinical Diagnosis
12.3. Disease Monitoring
12.4. Drug Development
13. Renal Biomarkers Market, by End User
13.1. Academic And Research Institutes
13.2. Contract Research Organizations
13.3. Hospitals And Diagnostic Labs
13.4. Pharmaceutical Companies
14. Renal Biomarkers Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Renal Biomarkers Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Renal Biomarkers Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Renal Biomarkers Market
18. China Renal Biomarkers Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. AstraZeneca PLC
19.7. Bayer AG
19.8. Bio-Rad Laboratories, Inc.
19.9. bioMérieux SA
19.10. BioPorto Diagnostics A/S
19.11. Cipla Limited
19.12. Danaher Corporation
19.13. DiaSorin S.p.A.
19.14. Eli Lilly and Co
19.15. Enzo Biochem, Inc.
19.16. Eurofins Viracor Inc.
19.17. F. Hoffmann-La Roche Ltd.
19.18. Fresenius Kabi AG
19.19. Novartis AG
19.20. Novatein Biosciences Inc.
19.21. PerkinElmer Inc.
19.22. Randox Laboratories Ltd.
19.23. Renalytix AI PLC
19.24. Sanofi-Aventis, LLC.
19.25. Sekisui Diagnostics, LLC
19.26. Siemens Healthineers AG
19.27. SphingoTec GmbH
19.28. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL RENAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL RENAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL RENAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES RENAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA RENAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL RENAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SPECTROPHOTOMETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SPECTROPHOTOMETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SPECTROPHOTOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY COLORIMETRIC KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY COLORIMETRIC KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY COLORIMETRIC KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY TRAINING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY TRAINING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY TRAINING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY LABORATORY INFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY LABORATORY INFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY LABORATORY INFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CREATININE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CREATININE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CREATININE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CYSTATIN C, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CYSTATIN C, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CYSTATIN C, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY NGAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY NGAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY NGAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY BIOSENSORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY BIOSENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY COLORIMETRIC ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY COLORIMETRIC ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY COLORIMETRIC ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY LC-MS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY LC-MS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY LC-MS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SERUM PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SERUM PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY SERUM PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CLINICAL DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CLINICAL DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. EUROPE RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. EUROPE RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 160. EUROPE RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 161. EUROPE RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 163. EUROPE RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. EUROPE RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 165. EUROPE RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. EUROPE RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. AFRICA RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. AFRICA RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. AFRICA RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 181. AFRICA RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 182. AFRICA RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 183. AFRICA RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 184. AFRICA RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 185. AFRICA RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. AFRICA RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 187. AFRICA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. AFRICA RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. ASEAN RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. ASEAN RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 203. ASEAN RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 204. ASEAN RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 205. ASEAN RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 206. ASEAN RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 207. ASEAN RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 208. ASEAN RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. ASEAN RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 210. ASEAN RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. ASEAN RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. GCC RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. GCC RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. GCC RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 215. GCC RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 216. GCC RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 217. GCC RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 218. GCC RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 219. GCC RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 220. GCC RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 221. GCC RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. GCC RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. BRICS RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. BRICS RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 236. BRICS RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 237. BRICS RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 238. BRICS RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 239. BRICS RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 240. BRICS RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 241. BRICS RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 242. BRICS RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 243. BRICS RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. BRICS RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. G7 RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. G7 RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. G7 RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 248. G7 RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 249. G7 RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 250. G7 RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 251. G7 RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 252. G7 RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 253. G7 RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 254. G7 RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. G7 RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. NATO RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 257. NATO RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 258. NATO RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 259. NATO RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 260. NATO RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 261. NATO RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 262. NATO RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 263. NATO RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 264. NATO RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 265. NATO RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 266. NATO RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL RENAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES RENAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. CHINA RENAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 280. CHINA RENAL BIOMARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 281. CHINA RENAL BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 282. CHINA RENAL BIOMARKERS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 283. CHINA RENAL BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 284. CHINA RENAL BIOMARKERS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 285. CHINA RENAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 286. CHINA RENAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 287. CHINA RENAL BIOMARKERS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 288. CHINA RENAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 289. CHINA RENAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Renal Biomarkers market report include:
  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • BioPorto Diagnostics A/S
  • Cipla Limited
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eli Lilly and Co
  • Enzo Biochem, Inc.
  • Eurofins Viracor Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • Novartis AG
  • Novatein Biosciences Inc.
  • PerkinElmer Inc.
  • Randox Laboratories Ltd.
  • Renalytix AI PLC
  • Sanofi-Aventis, LLC.
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • SphingoTec GmbH
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.68 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.74 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Renal Biomarkers Market Forecast to 2033 - Product Image

Renal Biomarkers Market Forecast to 2033

  • Report
  • 150 Pages
  • Global
From
Renal Biomarkers Market Report by Biomarker Type, Diagnostic Technique, End User, and Region 2025-2033 - Product Image

Renal Biomarkers Market Report by Biomarker Type, Diagnostic Technique, End User, and Region 2025-2033

  • Report
  • 148 Pages
  • Global
From
Renal Biomarkers Market Report and Forecast 2025-2034 - Product Image

Renal Biomarkers Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Renal Biomarkers - Global Strategic Business Report - Product Image

Renal Biomarkers - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Renal Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Renal Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 186 Pages
  • Global
From

About the Market

Biomarkers are biological molecules that can be used to measure and monitor the progression of a disease or condition. Kidney markers are a type of biomarker used to measure the health of the kidneys. They are typically used to diagnose and monitor kidney diseases, such as chronic kidney disease, acute kidney injury, and glomerulonephritis. Kidney markers can also be used to assess the effectiveness of treatments for kidney diseases. Kidney markers are typically measured through blood tests, urine tests, or imaging tests. Commonly used kidney markers include creatinine, cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL). These markers can be used to measure the level of kidney function, as well as to detect the presence of kidney damage. The kidney marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of kidney diseases, as well as the growing demand for more accurate and reliable diagnostic tests. The market is expected to continue to grow in the coming years, as new technologies and biomarkers are developed. Some companies in the kidney marker market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Beckman Coulter. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.